PAUL ARAULLO: Open Payments
NPI 1053744870 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 7 companies in 2025. Trend: 2023 $2,272 · 2024 $2,274 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $285 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $35 |
| Lundbeck LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: ARISTADA, INVEGA SUSTENNA, INGREZZA, VRAYLAR, REXULTI, CAPLYTA.
Industry payments across CA — which companies pay providers there.
